Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.07M Buy
41,230
+3,730
+10% +$546K 0.43% 47
2025
Q4
$4.56M Sell
37,500
-340
-0.9% -$39.9K 0.33% 61
2025
Q3
$4.08M Buy
37,840
+3,260
+9% +$304K 0.32% 63
2025
Q2
$3.07M Sell
34,580
-460
-1% -$34.6K 0.28% 69
2025
Q1
$2.43M Sell
35,040
-1,600
-4% -$115K 0.26% 76
2024
Q4
$2.71M Buy
36,640
+5,880
+19% +$397K 0.27% 69
2024
Q3
$2.04M Buy
30,760
+9,800
+47% +$769K 0.24% 82
2024
Q2
$1.46M Buy
20,960
+720
+4% +$53.2K 0.21% 89
2024
Q1
$1.41M Buy
20,240
+6,910
+52% +$444K 0.21% 87
2023
Q4
$775K Buy
13,330
+1,830
+16% +$95.3K 0.17% 119
2023
Q3
$527K Sell
11,500
-270
-2% -$12.9K 0.18% 125
2023
Q2
$571K Buy
11,770
+70
+0.6% +$2.92K 0.21% 113
2023
Q1
$451K Buy
+11,700
New +$461K 0.19% 125

Other funds holding KLAC

Fidelis Capital Partners's KLAC Position: Q1 2026 in Review

Fidelis Capital Partners increased its KLA (KLAC) stake by 9.9% in Q1 2026, buying an estimated $546K and bringing the position to 41,230 shares worth $6.07M. The position accounts for 0.43% of the portfolio, ranked #47.

Fidelis Capital Partners first reported a position in KLAC in Q1 2023 and has held it in 13 quarters since. 2,063 funds tracked by Wall St. Rank hold KLAC as of Q1 2026.

  • Fidelis Capital Partners held 41,230 shares of KLA worth $6.07M as of Q1 2026.
  • Fidelis Capital Partners bought 3,730 KLA shares in Q1 2026, an estimated $546K.
  • KLA made up 0.43% of Fidelis Capital Partners's portfolio in Q1 2026, its #47 holding.
  • Fidelis Capital Partners first reported a position in KLA in Q1 2023 and has held it in 13 quarters since.
  • 2,063 funds tracked by Wall St. Rank held KLA as of Q1 2026.

Based on Fidelis Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.